An 8.6 magnitude earthquake occurred 62 miles off the coast of Sumatra on April 11th, 2012. 

Along with being severe by any measure, in one way it was the largest earthquake in observed human history; it originated within the plate rather than at a plate boundary.

The quake originated under the Wharton Basin in the Indian Ocean, where hundreds of miles of rock were under crushing tension, causing the plate to deform at its base. This 'deforming zone' was also absorbing tension as two plates, the Indian and Australian plates, rotated toward each other. 

Boston Scientific Corporation has received CE Mark approval for use of its PRECISION(TM) PLUS SPINAL CORD STIMULATOR (SCS) System in patients with the system and are in need for magnetic resonance imaging (MRI) head-only scans. The PRECISION PLUS SCS System is the world's first rechargeable SCS device. This approval provides physicians with an additional diagnostic option for patients with chronic intractable pain. 

Remember The-Shadow-Scholar, the deeply disturbing confirmation of that academia generally selects for meaningless drivel while making critical information unheard; the story that especially academic media try to contain as a side issue about student writing although it is obviously symptomatic of the whole of academia and much of modern society?

Cutting carbon dioxide emissions is not easy; it requires a buy-in from developing nations who have coal and want a better life also, or a greater implementation of natural gas. One alternative idea is to transport materials into the stratosphere to reduce the amount of sunlight hitting Earth and therefore reduce the effects of global climate change.

A new paper says that the basic technology currently exists and could be assembled and implemented in a number of different forms for less than $5 billion a year - a tiny fraction of the amount that cutting emissions costs. Put into context, the cost of reducing carbon dioxide emissions is currently estimated to be between 0.2 and 2.5 per cent of GDP in the year 2030, which is equivalent to $200 billion to $2 trillion.

Researchers have found that a human monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) protected chimpanzees from hepatitis C virus (HCV) infection in a dose-dependent manner.

The study was conducted at Texas Biomed's Southwest National Primate Research Center.  Chimpanzees are the only species other than humans that can be infected by HCV and therefore the results from this study were critical in the development of the monoclonal antibody.